0000899243-20-004963.txt : 20200218
0000899243-20-004963.hdr.sgml : 20200218
20200218192745
ACCESSION NUMBER: 0000899243-20-004963
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200213
FILED AS OF DATE: 20200218
DATE AS OF CHANGE: 20200218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAHAFFY PATRICK J
CENTRAL INDEX KEY: 0001266569
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35347
FILM NUMBER: 20627085
MAIL ADDRESS:
STREET 1: C/O CLOVIS ONCOLOGY, INC.
STREET 2: 5500 FLATIRON PARKWAY, SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clovis Oncology, Inc.
CENTRAL INDEX KEY: 0001466301
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 900475355
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: (303) 625-5000
MAIL ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-13
0
0001466301
Clovis Oncology, Inc.
CLVS
0001266569
MAHAFFY PATRICK J
C/O CLOVIS ONCOLOGY, INC.
5500 FLATIRON PARKWAY, SUITE 100
BOULDER
CO
80301
1
1
0
0
President and CEO
Stock Option (right to buy)
9.71
2020-02-13
4
A
0
50000
0.00
A
2030-02-13
Common Stock
50000
50000
D
The option shall vest in the event the Company's Product Revenues for the Company's fiscal year ending December 31, 2020 meet or exceed its corresponding budgeted amount in the Company's budget as approved by the Board of Directors on February 13, 2020.
/s/ Patrick J. Mahaffy
2020-02-18